‘Ozempic Effect’: How GLP-1s are changing shopping habits

Millions of Americans are shrinking out of their clothes faster than retailers can restock the shelves, and stores are scrambling to catch up.

Quick Take

About 23% of U.S. households used GLP-1 weight-loss drugs like Ozempic and Wegovy as of last September, up four points from the year before.
Circana data shows 80% of GLP-1 users expect to need new clothes, and 55% already bought some.
Sales of larger bra sizes are slowing while mid- and small-size bras are growing, an early warning sign for retailers.
Analysts at PwC found apparel spending jumps nearly 10% after six to eight months on the drugs.
Retailers admit they’re still in the “early stages” of adjusting sizing, fitting rooms, and store service.

A Fast-Growing Group of Shoppers Is Changing Size

More than one in five U.S. households now has someone using a GLP-1 drug, and that number keeps climbing. These medications, sold under names like Ozempic, Wegovy, Mounjaro, and Zepbound, cause rapid weight loss for many users. Retail data firm Circana says this shift is now an “emerging transformational force” for the clothing industry, not a passing fad.

Wardrobes Are Being Replaced, Not Just Refreshed

Circana found 80% of GLP-1 users expect they’ll need new clothes because their bodies are changing, and 55% have already bought new pieces for that reason. PwC’s research backs this up, showing apparel spending rises almost 10% after six to eight months of treatment, with 73% of users reporting a real change in clothing size. At the same time, grocery spending drops as users eat less and skip snacks and alcohol.

The bra business offers one of the clearest signals so far. Sales of larger band sizes and D-cup and above are slowing, while mid- to small-size bras are climbing. Impact Analytics, a separate research firm, warns this size-curve shift could put up to $5 billion in apparel inventory at risk if brands don’t adjust what they stock.

Stores Are Betting Big, But Still Guessing

Retailers see a business opportunity in the millions of people losing weight and wanting new outfits to show it off. Some analysts project the trend could add as much as $13 billion a year in clothing sales. Personal styling service Stitch Fix says more customers now cite weight loss as their reason for shopping. But most of these numbers are still projections, not confirmed sales results. Reuters reports that major chains like Ross and Urban Outfitters have posted sales gains, but neither company has directly credited GLP-1 drugs for the boost. That gap between what retailers say publicly and what analysts assume behind the scenes is a real limit on how much of this story is proven fact versus educated guesswork.

Shoppers Are Returning to Fitting Rooms — and to Returns Counters

Because bodies are changing fast, many GLP-1 users say they don’t trust online size charts anymore. One survey found 69% of users now shop more in-store because they’re unsure what size fits, and 65% buy multiple sizes of the same item just in case. That habit is driving up returns, forcing retailers to rethink logistics built around stable body sizes.

GLP-1 adoption is reviving in-store apparel demand: 2/3 of users shop in person more as sizing changes. Retailers with strong fitting and styling services can capture the shift. 🛍️ pic.twitter.com/rgNn7d5oEV

— Viktor Kopylov (@si14bank) August 2, 2026

Not every shopper cuts ties with their old wardrobe right away. One study found nearly 70% of GLP-1 users still buy clothes in their old sizes sometimes, and more than half keep old clothing out of fear they’ll regain the weight. That mix of confidence and caution shows this shift in shopping habits is real, even if it’s messier and slower than some headlines suggest. Consultants say retailers are still adjusting sizing and inventory plans, not finished with the job.